{"id":"dapt-statin","safety":{"commonSideEffects":[{"rate":"5-10%","effect":"Bleeding"},{"rate":"1-5%","effect":"Thrombocytopenia"},{"rate":"null","effect":"Cerebrovascular accident"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"DAPT works by selectively and reversibly inhibiting the P2Y12 receptor on platelet surfaces, which prevents adenosine diphosphate (ADP) from binding and activating platelets. This action reduces platelet aggregation and subsequent thrombus formation.","oneSentence":"DAPT inhibits platelet aggregation by blocking the P2Y12 receptor.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T03:31:15.648Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Acute coronary syndrome"},{"name":"Myocardial infarction"},{"name":"Ischemic stroke"}]},"trialDetails":[{"nctId":"NCT07032389","phase":"PHASE2","title":"A Polypill for Acute Coronary Syndrome","status":"RECRUITING","sponsor":"University of Texas Southwestern Medical Center","startDate":"2025-12-05","conditions":"Acute Coronary Syndrome","enrollment":1000},{"nctId":"NCT06090890","phase":"PHASE4","title":"Anti-inflammatory Therapy for Recurrent In-stent Restenosis","status":"RECRUITING","sponsor":"Fu Wai Hospital, Beijing, China","startDate":"2023-10-30","conditions":"In-stent Restenosis","enrollment":252},{"nctId":"NCT06564909","phase":"PHASE2","title":"Effect of L-Carnitine on Biomarkers of Myocardial Reperfusion Injury in Patients With STEMI","status":"RECRUITING","sponsor":"Ain Shams University","startDate":"2025-06-01","conditions":"Reperfusion Injury, Myocardial, Myocardial Infarction","enrollment":76},{"nctId":"NCT06899399","phase":"NA","title":"Efficacy and Safety Study of Endovascular Treatment of Asymptomatic Carotid Artery Stenosis","status":"RECRUITING","sponsor":"Beijing Tiantan Hospital","startDate":"2024-10-18","conditions":"Asymptomatic Carotid Artery Stenosis","enrollment":982},{"nctId":"NCT05360602","phase":"NA","title":"Alpha Lipoic Acid Effect on No-Reflow Phenomenon","status":"COMPLETED","sponsor":"Ain Shams University","startDate":"2022-01-01","conditions":"No-Reflow Phenomenon","enrollment":70},{"nctId":"NCT05122780","phase":"PHASE4","title":"Prognostic Value of Precision Medicine in Patients With MINOCA (PROMISE Trial).","status":"ACTIVE_NOT_RECRUITING","sponsor":"Fondazione Policlinico Universitario Agostino Gemelli IRCCS","startDate":"2021-07-01","conditions":"Myocardial Infarction With Non-Obstructive Coronary Arteries","enrollment":120},{"nctId":"NCT03635749","phase":"PHASE3","title":"Intensive Medical Therapy for High-risk Intracranial or Extracranial Atherosclerosis","status":"UNKNOWN","sponsor":"Beijing Tiantan Hospital","startDate":"2018-09-17","conditions":"Acute Stroke, Transient Ischemic Attack","enrollment":6100},{"nctId":"NCT05045274","phase":"NA","title":"The Effect of Early Administration of Dapagliflozin in STEMI Patients With LV Systolic Dysfunction","status":"UNKNOWN","sponsor":"Assiut University","startDate":"2021-12","conditions":"STEMI - ST Elevation Myocardial Infarction, Left Ventricular Systolic Dysfunction","enrollment":300},{"nctId":"NCT04538924","phase":"NA","title":"Etiologic Mechanisms, Myocardial Changes and Prognosis of Patients With MINOCA","status":"UNKNOWN","sponsor":"Vilnius University Hospital Santaros Klinikos","startDate":"2019-01-01","conditions":"Myocardial Infarction With Nonobstructive Coronary Arteries","enrollment":150},{"nctId":"NCT03785509","phase":"","title":"The Compliance of DAPT and Statins on Clinical Outcomes in Percutaneous Coronary Intervention Patients","status":"COMPLETED","sponsor":"Samsung Medical Center","startDate":"2017-04-06","conditions":"Platelet Aggregation Inhibitors, Hydroxymethylglutaryl-coa Reductase Inhibitors, Compliance, Medication","enrollment":47291}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":52,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["DES, BMS"],"phase":"phase_2","status":"active","brandName":"DAPT, Statin","genericName":"DAPT, Statin","companyName":"Samsung Medical Center","companyId":"samsung-medical-center","modality":"Small molecule","firstApprovalDate":"","aiSummary":"DAPT inhibits platelet aggregation by blocking the P2Y12 receptor. Used for Acute coronary syndrome, Myocardial infarction, Ischemic stroke.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":1,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}